These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
621 related items for PubMed ID: 21913948
21. Distribution of CYP2C19*17 allele and genotypes in an Indian population. Anichavezhi D, Chakradhara Rao US, Shewade DG, Krishnamoorthy R, Adithan C. J Clin Pharm Ther; 2012 Jun; 37(3):313-8. PubMed ID: 21916910 [Abstract] [Full Text] [Related]
22. Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam. Veiga MI, Asimus S, Ferreira PE, Martins JP, Cavaco I, Ribeiro V, Hai TN, Petzold MG, Björkman A, Ashton M, Gil JP. Eur J Clin Pharmacol; 2009 Apr; 65(4):355-63. PubMed ID: 18979093 [Abstract] [Full Text] [Related]
23. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups. Li D, Zhang GL, Lou YQ, Li Q, Wang X, Bu XY. J Clin Pharm Ther; 2007 Feb; 32(1):89-95. PubMed ID: 17286792 [Abstract] [Full Text] [Related]
24. Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico. Salazar-Flores J, Torres-Reyes LA, Martínez-Cortés G, Rubi-Castellanos R, Sosa-Macías M, Muñoz-Valle JF, González-González C, Ramírez A, Román R, Méndez JL, Barrera A, Torres A, Medina R, Rangel-Villalobos H. Genet Test Mol Biomarkers; 2012 Sep; 16(9):1098-104. PubMed ID: 22913530 [Abstract] [Full Text] [Related]
26. Relevance of the ancestry for the variability of the Drug-Metabolizing Enzymes CYP2C9, CYP2C19 and CYP2D6 polymorphisms in a multiethnic Costa Rican population. Céspedes-Garro C, Rodrigues-Soares F, Jiménez-Arce G, Naranjo MG, Tarazona-Santos E, Fariñas H, Barrantes R, Llerena A, CEIBA.FP Consortium of the Ibero-American Network of Pharmacogenetics & Pharmacogenomics RIBEF. Rev Biol Trop; 2016 Sep; 64(3):1067-76. PubMed ID: 29461783 [Abstract] [Full Text] [Related]
27. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population. Bozina N, Granić P, Lalić Z, Tramisak I, Lovrić M, Stavljenić-Rukavina A. Croat Med J; 2003 Aug; 44(4):425-8. PubMed ID: 12950145 [Abstract] [Full Text] [Related]
28. CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in South-East and East Asian populations: A systematic review. Dorji PW, Tshering G, Na-Bangchang K. J Clin Pharm Ther; 2019 Aug; 44(4):508-524. PubMed ID: 30980418 [Abstract] [Full Text] [Related]
29. The high prevalence of the poor and ultrarapid metabolite alleles of CYP2D6, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 in Taiwanese population. Liou YH, Lin CT, Wu YJ, Wu LS. J Hum Genet; 2006 Aug; 51(10):857. PubMed ID: 16924387 [Abstract] [Full Text] [Related]
30. Association of genetic polymorphisms of CYP 2C19 with hypertension in a Chinese Han population. Ma Y, Ni W, Zhu W, Xiong Y, Deng X. Blood Press; 2011 Jun; 20(3):166-70. PubMed ID: 21332417 [Abstract] [Full Text] [Related]
34. Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study. Dodgen TM, Hochfeld WE, Fickl H, Asfaha SM, Durandt C, Rheeder P, Drögemöller BI, Wright GE, Warnich L, Labuschagne CD, van Schalkwyk A, Gaedigk A, Pepper MS. BMC Med Genet; 2013 Jan 29; 14():20. PubMed ID: 23356658 [Abstract] [Full Text] [Related]